Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aegis Therapeutics LLC
Aegis Therapeutics’ Intravail® Technology Selected as Winner in Pharmaceutical Technology's “Innovations in Pharma Science Awards” for 2008
January 23rd, 2009
Aegis Therapeutics LLC’s Intravail® transmucosal absorption enhancement technology has been selected as a winner in Pharmaceutical Technology's “Innovations in Pharma Science Awards.” Intravail® excipients make it possible to administer previously injectable-only drugs such as growth hormone, interferon, glucagon, and siRNA drugs through various non-invasive means including metered nasal sprays, flash dissolve buccal tablets, or oral formulations. Intravail® is featured in the December 2008 issue of Pharmaceutical Technology (Pharm Tech). Pharm Tech is a peer-reviewed publication serving 38,600 BPA-audited subscribers, the largest circulation in the industry, delivering practical,...
Source: Health Business Week (2009-01-23)
|
